Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

Researchers found 71 genetic regions linked to male pattern baldness, which account for 38% of its genetic risk.

Scientists have created a new hair loss treatment using ultrasound to deliver gene-editing particles, which resulted in up to 90% hair regrowth in mice.

Plant-based drugs are effective and safe alternatives for managing PCOS symptoms.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

AGA in children needs careful diagnosis due to low androgen levels and possible other causes.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

The conference highlighted new diagnostic tools, the role of genetics in hair loss, and emerging treatments.

Insulin resistance is linked to PCOS and can lead to other health issues, but treatments like metformin can help manage symptoms.

Exercise improves insulin sensitivity and hormone regulation in PCOS rats.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Melatonin helps regulate hair growth and protects the hair follicle from stress.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Future research on ectodysplasin should explore its role in diseases, stem cells, and evolution, and continue developing treatments for genetic disorders like hypohidrotic ectodermal dysplasia.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Some alopecia treatments might help treat COVID-19, but more research is needed.

Finasteride affects offspring's antioxidant enzymes in epididymis, possibly disrupting sperm maturation.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

Scientists have found specific genes linked to different hair loss conditions, which could lead to new treatments.